 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
As Novartis Prenatal Pact Ends, Fluidigm Offers IP to Others, Continues Single-Cell Genomics Push
May 10, 2012
As Novartis Prenatal Pact Ends, Fluidigm Offers IP to Others, Continues Single-Cell Genomics Push
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Report Sees Continued Growth for Fluidigm as Company Remains 'Interesting' Acquisition Target
May 31, 2012 / PCR Insider - With 'Line of Sight' to Clinical Apps, GIS, Fluidigm Open Asia's First Single-Cell Genomics Center
April 16, 2013 / BioArray News - Fluidigm Developing Cellular Sample Prep Platform for Single-Cell Gene Expression, NGS Studies
May 17, 2012 / PCR Insider - Fluidigm, Novartis End Pact Aimed at Non-invasive Fetal Diagnostic Test
May 7, 2012 / GenomeWeb Daily News - Trovagene Bets on Digital PCR as Detection Technology for Urine-Based MDx Testing Platform
May 3, 2012 / PCR Insider